Cargando…

Associations of serum DNA methylation levels of chemokine signaling pathway genes with mild cognitive impairment (MCI) and Alzheimer’s disease (AD)

OBJECTIVE: To investigate the associations of serum DNA methylation levels of chemokine signaling pathway genes with Alzheimer’s disease (AD) and mild cognitive impairment (MCI) in elderly people in Xinjiang, China, and to screen out genes whose DNA methylation could distinguish AD and MCI. MATERIAL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zou, Ting, Zhou, Xiaohui, Wang, Qinwen, Zhao, Yongjie, Zhu, Meisheng, Zhang, Lei, Chen, Wei, Abuliz, Pari, Miao, Haijun, Kabinur, Keyimu, Alimu, Kader
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691689/ https://www.ncbi.nlm.nih.gov/pubmed/38039290 http://dx.doi.org/10.1371/journal.pone.0295320

Ejemplares similares

Significant association of 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) rs3846662 and sirtuin 1 (SIRT1) rs7895833 and apolipoprotein E (APOE) hypermethylation with mild cognitive impairment (MCI)
por: Zou, Ting, et al.
Publicado: (2019)

Association of multiple candidate genes with mild cognitive impairment in an elderly Chinese Uygur population in Xinjiang
por: Zou, Ting, et al.
Publicado: (2019)

Hierarchical Interactions Model for Predicting Mild Cognitive Impairment (MCI) to Alzheimer's Disease (AD) Conversion
por: Li, Han, et al.
Publicado: (2014)

The Predicted Key Molecules, Functions, and Pathways That Bridge Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)
por: Tao, Ye, et al.
Publicado: (2020)

Brain Resources: How Semantic Cueing Works in Mild Cognitive Impairment due to Alzheimer’s Disease (MCI-AD)
por: Brugnolo, Andrea, et al.
Publicado: (2021)

Structural Brain Imaging Phenotypes of Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD) Found by Hierarchical Clustering
por: Kärkkäinen, Mikko, et al.
Publicado: (2020)

Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD)
por: Bauckneht, Matteo, et al.
Publicado: (2018)

Use of mild cognitive impairment and prodromal AD/MCI due to AD in clinical care: a European survey
por: Bertens, Daniela, et al.
Publicado: (2019)

The paradox of opposite directions of gene expressions in MCI and AD suggests possible therapy to prevent progression of MCI to AD
por: Fessel, Jeffrey
Publicado: (2020)

The epidemiology of mild cognitive impairment (MCI) and Alzheimer’s disease (AD) in community-living seniors: protocol of the MemoVie cohort study, Luxembourg
por: Perquin, Magali, et al.
Publicado: (2012)

Decreased Retinal Vascular Density in Alzheimer’s Disease (AD) and Mild Cognitive Impairment (MCI): An Optical Coherence Tomography Angiography (OCTA) Study
por: Wang, Xi, et al.
Publicado: (2021)

Episodic Memory in Amnestic Mild Cognitive Impairment (aMCI) and Alzheimer’s Disease Dementia (ADD): Using the “Doors and People” Tool to Differentiate between Early aMCI—Late aMCI—Mild ADD Diagnostic Groups
por: Chatzikostopoulos, Athanasios, et al.
Publicado: (2022)

An MRI-Derived Definition of MCI-to-AD Conversion for Long-Term, Automatic Prognosis of MCI Patients
por: Aksu, Yaman, et al.
Publicado: (2011)

In the Hands of Hypnos: Associations between Sleep, Cognitive Performance and Financial Capacity in aMCI and Mild AD
por: Giannouli, Vaitsa, et al.
Publicado: (2023)

Cognitive variability—A marker for incident MCI and AD: An analysis for the Alzheimer's Disease Neuroimaging Initiative
por: Anderson, Eric D., et al.
Publicado: (2016)

Risk Factors for Mild Cognitive Impairment (MCI)
por: Loftus, Andrea Mary
Publicado: (2017)

Heterogeneity of Tau Deposition and Microvascular Involvement in MCI and AD
por: Bryant, Annie G., et al.
Publicado: (2021)

EEG Patterns in Mild Cognitive Impairment (MCI) Patients
por: Baker, Mary, et al.
Publicado: (2008)

AD-NET: Age-adjust neural network for improved MCI to AD conversion prediction
por: Gao, Fei, et al.
Publicado: (2020)

Mild Cognitive Impairment with a High Risk of Progression to Alzheimer’s Disease Dementia (MCI-HR-AD): Effect of Souvenaid(®) Treatment on Cognition and (18)F-FDG PET Scans
por: Manzano Palomo, Maria Sagrario, et al.
Publicado: (2019)

Disrupted balance of long and short-range functional connectivity density in Alzheimer’s disease (AD) and mild cognitive impairment (MCI) patients: a resting-state fMRI study
por: Mao, Yanping, et al.
Publicado: (2021)

Neural correlates of lexical-semantic memory: A voxel-based morphometry study in mild AD, aMCI and normal aging
por: Balthazar, Marcio L.F., et al.
Publicado: (2011)

Targeted lipidomics distinguishes patient subgroups in mild cognitive impairment (MCI) and late onset Alzheimer's disease (LOAD)
por: Wood, Paul L., et al.
Publicado: (2015)

The Test Your Memory for Mild Cognitive Impairment (TYM-MCI)
por: Brown, Jeremy M, et al.
Publicado: (2017)

Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers
por: Shen, Li, et al.
Publicado: (2013)

Added value of amyloid PET in individualized risk predictions for MCI patients
por: van Maurik, Ingrid S., et al.
Publicado: (2019)

Sleep Disturbances in MCI and AD: Neuroinflammation as a Possible Mediating Pathway
por: Pak, Victoria M., et al.
Publicado: (2020)

Head injury is associated with tau deposition on PET in MCI and AD patients
por: Risacher, Shannon L., et al.
Publicado: (2021)

Brain signatures based on structural MRI: Classification for MCI, PMCI, and AD
por: Gonuguntla, Venkateswarlu, et al.
Publicado: (2022)

Performance of a sample of patients with Mild Cognitive Impairment (MCI), Alzheimer's Disease (AD) and healthy elderly on a lexical decision test (LDT) as a measure of pre-morbid intelligence
por: Serrao, Valéria Trunkl, et al.
Publicado: (2015)

Direction of Information Flow in Alzheimer's Disease and MCI Patients
por: Vecchio, Fabrizio, et al.
Publicado: (2011)

Interactive versus additive relationships between regional cortical thinning and amyloid burden in predicting clinical decline in mild AD and MCI individuals
por: d'Oleire Uquillas, Federico, et al.
Publicado: (2017)

Neuropsychological comparison of incident MCI and prevalent MCI
por: Hansen, Allison, et al.
Publicado: (2018)

Feasibility of Predicting MCI/AD Using Neuropsychological Tests and Serum β-Amyloid
por: Luis, Cheryl A., et al.
Publicado: (2011)

Baseline MRI Predictors of Conversion from MCI to Probable AD in the ADNI Cohort
por: Risacher, Shannon L, et al.
Publicado: (2009)

Spatial distributions of cholinergic impairment and neuronal hypometabolism differ in MCI due to AD
por: Richter, Nils, et al.
Publicado: (2019)

Free Water in White Matter Differentiates MCI and AD From Control Subjects
por: Dumont, Matthieu, et al.
Publicado: (2019)

Problems in Classifying Mild Cognitive Impairment (MCI): One or Multiple Syndromes?
por: Díaz-Mardomingo, María del Carmen, et al.
Publicado: (2017)

Screening for Mild Cognitive Impairment: Comparison of “MCI Specific” Screening Instruments
por: O’Caoimh, Rónán, et al.
Publicado: (2016)

The effects of dexmedetomidine on the cognitive function of mild cognitive impairment (MCI) rats
por: Zhou, Qian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vch56v246fog9sqtsan0b376uh